Sitemap - 2023 - Mendelspod
Kevin Davies on Gene Therapy in 2023
History and State of Proteomics 2023 with John Yates
Ukrainian American Biotech CEO on the War in Ukraine
Will the Precision Medicine Industry Bounce Back?
Seasons Greetings, Fans of Mendelspod!
New Philosophy of Biology Series on PBS: A Preview with Host Robert Lawrence Kuhn
Mapping the Meta Proteome: John Shon, CTO, Serimmune
Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech
Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing
Thank you. We're getting close!
State of Sequencing 2023: Shawn Baker and Keith Robison
Newborn Sequencing 2023 Part II: What Evidence Is Enough?
Zack Abbott on Engineered Probiotics and GMOs
Lincoln Nadauld on the State of Precision Medicine in 2023
Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio
Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific
Theral's Picks: The FDA Moves (Again) to Regulate LDTs
This Is Very Cool: Treating Cancer with Sound
The Future of Clinical Proteomics with Jenny Van Eyk and Daniel Hornburg
The State of Newborn Sequencing in 2023: A Panel Discussion
Elinor Karlsson on Darwin’s Ark
Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech
New Illumina CEO, Venter Book, and New Yorker Takes on He Jiankui
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
13th Season Opener: Mike Snyder on Microsampling and Multi-Omic Profiling
Addressing Racial Bias in Healthcare AI: Elliott Green of Dandelion Health
An Update on the GUARDIAN Newborn Sequencing Study with Wendy Chung
Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel
Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI
Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023
Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin
Elegen Pioneers Long DNA Subindustry with CEO Matt Hill
Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More
3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics
New Spatial Company Maps Cell Surface Proteome without Imaging
John Greally on His Latest Review of Epigenomics
President of ASHG on Eugenics Apology, Diversity Initiative
23andMe Launches New Personalized Healthcare Initiative with Amy Sturm
Converting Digital to Biological: John Gill, Telesis Bio
50% Not Tested: Precision Oncology with Jerome Madison, Invitae